← Open Payments lookup

SAMINA ASFANDIYAR: Open Payments

NPI 1306496211 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$428 in 6 payments from 6 companies in 2025. Trend: 2023 $2,253 · 2024 $2,530 · 2025 $428

Food & beverage: $348Education: $80
CompanyPaymentsAmount
Insulet Corporation1$116
Tandem Diabetes Care, Inc.1$108
Astellas Pharma US Inc1$80
Merck Sharp & Dohme LLC1$70
Deciphera Pharmaceuticals Inc.1$31
Incyte Corporation1$23

Products named: OMNIPOD, t:slim X2 Insulin Pump with Control-IQ, KEYTRUDA, QINLOCK, Jakafi.

Industry payments across TX — which companies pay providers there.